[{"NetIncomeLossConverted_4_FY_USD":-162600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":135400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":136100000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":0.9,"CommonStockSharesConverted_0_FY_shares":133100000.0,"Assets_0_FY_USD":11488400000.0,"RevenuesConverted_1_FY_USD":1289500000.0,"RevenuesConverted_4_FY_USD":5063300000.0,"StockholdersEquity_0_FY_USD":5655100000.0,"EarningsPerShareDiluted_4_FY_USD":-1.19,"EarningsPerShareDiluted_1_FY_USD":-1.29,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":636200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":136100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":135400000.0,"StockholdersEquityConverted_0_FY_USD":5655100000.0,"NetIncomeLossConverted_1_FY_USD":-175000000.0,"EarningsPerShareBasic_4_FY_USD":-1.19,"EarningsPerShareBasic_1_FY_USD":-1.29,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210301"}]